Faculty Digital Archive

Archive@NYU >
Stern School of Business >
Salomon Center >
Asset Management  >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2451/27435

Title: An Analysis of the Relative Performance of Japanese and Foreign Money Management
Authors: Brown, Stephen J.
Goetzmann, William N.
Hiraki, Takato
Shiraishi, Noriyoshi
Issue Date: 25-Sep-2002
Series/Report no.: SC-AM-02-05
Abstract: Foreign investment management firms have recently started to play a major role in the investment trust business in Japan. In terms of assets under management, their size and market share have almost doubled in the past several years. In part, the relative success of foreign managed firms in attracting market share may be attributed to the fact that Japanese investment trusts have underperformed benchmarks in quite a dramatic fashion over the past two decades. This is at best indirect evidence that Japanese funds underperform their foreign counterparts. In a recent paper (Brown, Goetzmann, Hiraki, Otsuki and Shiraishi 2001) we show that the underperformance can be attributed almost entirely to the unique tax environment of Japanese investment trusts, which had the effect of heavily penalizing early withdrawals. The relaxation of these regulations coincided with a major inflow of new money into the investment trust business. We examine the relative performance of Japanese and foreign investment management firms before and after this change in tax regulations, and find that the poor relative performance of Japanese funds from April 2000 through December 2001 may in part be attributed to the huge inflow of new money into this sector and the style shifts made necessary to accommodate this flow.
URI: http://hdl.handle.net/2451/27435
Appears in Collections:Asset Management

Files in This Item:

File Description SizeFormat
S-AM-02-05.pdf475.37 kBAdobe PDFView/Open

Items in Faculty Digital Archive are protected by copyright, with all rights reserved, unless otherwise indicated.


The contents of the FDA may be subject to copyright, be offered under a Creative Commons license, or be in the public domain.
Please check items for rights statements. For information about NYU’s copyright policy, see http://www.nyu.edu/footer/copyright-and-fair-use.html 
Valid XHTML 1.0 | CSS